U.S. Capital Wealth Advisors »

Summit Therapeutics shares owned by U.S. Capital Wealth Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by U.S. Capital Wealth Advisors from 13F filings

Historical chart of U.S. Capital Wealth Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by U.S. Capital Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by U.S. Capital Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $248k 12k 20.66
2025-06-30 $256k 12k 21.28
2025-03-31 $232k 12k 19.29